ok - prima is one of the best on asx, page-11

When Dendreon was in Prima's position in early 2008, they had a market cap of $500m (refer to a Prima announcement in March 2008)

Prima's current market cap is only $303m.

In theory, a NASDAQ listing could get us up to $500m market cap which is around 0.63 cents per share.

Since Dendreon has done extremely well since then, if the sentiment remains positive for Prima, we may well even exceed the $500m market cap, and give us a price between 65-75c prior to FDA approval. It might even be higher, but who knows? We can only SPECULATE.

In my opinion a market cap of $500m prior to FDA approval is a realistic and highly achievable target.

Good luck to all, and if you think you've missed the bus, don't be afraid to hop back on because we're not even half way in the medium term =)

Patience will be needed as these things take time, but I think it will get there.